TAFFIC 50 mg/200 mg/25 mg is a fixed-dose antiretroviral tablet containing Bictegravir 50 mg, Emtricitabine 200 mg, and Tenofovir Alafenamide 25 mg. TAFFIC was launched in India by Hetero as a three-drug, once-daily HIV-1 treatment option.
For international pharmaceutical buyers, distributors, wholesalers, hospitals, clinics, and licensed procurement organizations, sourcing medicines from India can provide access to a broad pharmaceutical manufacturing and supply network. However, TAFFIC is a prescription medicine, and international procurement must comply with the pharmaceutical import, registration, prescription, and customs requirements of the destination country.
TAFFIC 50/200/25 mg – Product Overview
| Product | TAFFIC |
|---|---|
| Active Ingredients | Bictegravir 50 mg + Emtricitabine 200 mg + Tenofovir Alafenamide 25 mg |
| Dosage Form | Tablet |
| Pack Size | 30 tablets |
| Therapeutic Category | Antiretroviral medicine |
| Primary Use | Treatment of HIV-1 infection |
| Manufacturer/Brand Information | TAFFIC / Hetero |
| Country of Origin | India |
| Prescription Status | Prescription medicine |
The product information available for TAFFIC identifies the formulation as Bictegravir 50 mg, Emtricitabine 200 mg and Tenofovir Alafenamide 25 mg, with a 30-tablet pack.
What Is TAFFIC Used For?
TAFFIC is an antiretroviral combination used for the treatment of HIV-1 infection. It combines three active pharmaceutical ingredients into a single tablet:
- Bictegravir – an integrase strand transfer inhibitor.
- Emtricitabine – a nucleoside reverse transcriptase inhibitor.
- Tenofovir alafenamide – a nucleotide reverse transcriptase inhibitor.
The combination is designed to inhibit different stages of HIV replication. Hetero describes TAFFIC as a once-daily single-pill regimen for appropriate patients.
TAFFIC does not cure HIV or AIDS. Treatment should be taken only under the direction and monitoring of an appropriately qualified healthcare professional.
Why Source TAFFIC from an Indian Pharmaceutical Exporter?
India has an established pharmaceutical manufacturing and export ecosystem serving buyers across numerous international markets. For licensed buyers, sourcing from India may offer advantages such as:
1. Established Pharmaceutical Supply Chain
Indian pharmaceutical suppliers operate extensive manufacturing, distribution, and export networks.
2. Competitive Procurement
Indian pharmaceutical products can offer competitive commercial terms depending on the product, destination, quantity, regulatory requirements, and shipping arrangement.
3. Export-Oriented Supply
Professional pharmaceutical exporters can coordinate documentation, commercial invoices, packing information, shipping arrangements, and other applicable export requirements.
4. Multiple Procurement Quantities
Commercial requirements can vary from smaller institutional purchases to larger wholesale procurement. Minimum order quantities should be confirmed before placing an order.
5. International Buyer Support
An experienced exporter can assist buyers with product specifications, quotations, availability, documentation, and shipping coordination, subject to applicable laws.
TAFFIC Export & International Trading
When purchasing TAFFIC for an international market, buyers should first verify that the medicine is permitted for import and distribution in the destination country.
Important considerations include:
- Import authorization or permit requirements
- Local product registration requirements
- Prescription and controlled-distribution rules
- Buyer licensing requirements
- Customs documentation
- Country-specific labeling requirements
- Product shelf-life requirements
- Shipping and storage conditions
- Regulatory requirements for HIV/antiretroviral medicines
- Payment and commercial documentation
Important: Availability for export does not automatically mean that TAFFIC can legally be imported or sold in every country. The buyer/importer is responsible for confirming the destination country's applicable pharmaceutical regulations.
Packaging & Product Information
TAFFIC is marketed as a tablet formulation containing:
Bictegravir 50 mg + Emtricitabine 200 mg + Tenofovir Alafenamide 25 mg
The commonly listed commercial pack contains 30 tablets.
Buyers should verify the actual batch, expiry date, packaging configuration, manufacturer/marketer details, and regulatory documentation before completing an international transaction.
How Does TAFFIC Work?
The three components of TAFFIC work through complementary antiretroviral mechanisms.
Bictegravir inhibits HIV integrase, an enzyme required for HIV genetic material to become incorporated into human DNA.
Emtricitabine and tenofovir alafenamide interfere with HIV reverse transcriptase, helping prevent the virus from producing new genetic material.
The combined action helps reduce HIV replication when the medicine is appropriately prescribed and taken as directed.
Important Safety Information
TAFFIC should be used only according to a healthcare professional's prescription and instructions.
Patients should inform their healthcare provider about:
- Existing medical conditions
- Other prescription medicines
- Over-the-counter medicines
- Vitamins and supplements
- Antacids or mineral supplements
- Previous HIV treatment
- Hepatitis B infection or history
TAFFIC information specifically warns that stopping treatment in a person who also has hepatitis B can result in worsening of HBV infection. It also provides specific instructions regarding certain iron- or calcium-containing supplements and antacids.
Patients should not stop, change, or restart antiretroviral therapy without medical advice.
TAFFIC Trading FAQs
1. What is TAFFIC 50/200/25 mg?
TAFFIC is an antiretroviral combination tablet containing Bictegravir 50 mg, Emtricitabine 200 mg, and Tenofovir Alafenamide 25 mg. It is used for the treatment of HIV-1 infection.
2. What is the pack size of TAFFIC?
TAFFIC is commonly supplied in a 30-tablet pack. Buyers should confirm the current packaging configuration before ordering.
3. Who can purchase TAFFIC for export?
Licensed pharmaceutical distributors, wholesalers, hospitals, healthcare organizations, procurement agencies, and other legally authorized buyers may inquire, subject to the regulations of the exporting and importing countries.
4. Can TAFFIC be exported from India?
International supply may be possible subject to Indian export regulations and the destination country's pharmaceutical import requirements. Buyers should confirm local registration, licensing, import permits, and other applicable requirements before ordering.
5. Is TAFFIC a prescription medicine?
Yes. TAFFIC is a prescription antiretroviral medicine and should be supplied and used according to applicable medical and pharmaceutical regulations.
6. What are the active ingredients in TAFFIC?
Each tablet contains:
- Bictegravir 50 mg
- Emtricitabine 200 mg
- Tenofovir Alafenamide 25 mg
7. Is TAFFIC the same as Biktarvy?
TAFFIC contains the same three active ingredients and strengths as the well-known Biktarvy formulation. Hetero describes TAFFIC as the generic version of Biktarvy launched in India.
8. What documents may be required for pharmaceutical export?
Depending on the transaction and destination, documentation can include commercial invoices, packing lists, shipping documents, product documentation, export declarations, licenses, certificates, and destination-country import documentation.
9. Can you provide a quotation for TAFFIC?
Yes. International buyers can contact our export team with their required quantity, destination country, and preferred shipping terms to request a commercial quotation.
10. Can you supply TAFFIC in bulk?
Bulk procurement can be discussed based on product availability, buyer requirements, destination regulations, and applicable minimum order quantities.
11. How should TAFFIC be stored?
Storage conditions should follow the product's approved packaging and official product information. Buyers should verify the current manufacturer's storage instructions for the specific batch being procured.
12. Can patients purchase TAFFIC directly for self-treatment?
TAFFIC should not be self-prescribed. HIV treatment requires professional medical evaluation, appropriate testing, monitoring, and a suitable antiretroviral regimen.
TAFFIC Export Buyer Checklist
Before placing an international order, buyers should provide:
- Destination country
- Required quantity
- Buyer/company details
- Import license or authorization where applicable
- Required documentation
- Preferred shipping method
- Required delivery location
- Any destination-specific packaging or labeling requirements
This information helps an exporter assess the transaction and provide an appropriate quotation.
Why Choose MEDINDIA EXPORT?
MEDINDIA EXPORT supports international pharmaceutical sourcing from India for eligible buyers. Our export team can assist with product inquiries, quotations, order coordination, documentation requirements, and international shipping arrangements, subject to applicable regulations.
For TAFFIC inquiries, please share your country, required quantity, and buyer/company details with our team.
Contact MEDINDIA EXPORT
🌐 Website: www.medicineindiaexport.com
📧 Email: sales.medindiaexport@gmail.com
📱 WhatsApp: +91 7218129896
Contact us today for TAFFIC 50 mg/200 mg/25 mg availability, export quotation, packaging information, and international trading inquiries.
